[Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism]
[Article in
German]
- PMID: 4558132
Item in Clipboard
[Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism]
[Article in
German]
Wien Med Wochenschr.
.
No abstract available
Similar articles
-
[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].Rev Med Chil. 1973 Jun;101(6):452-5. Rev Med Chil. 1973. PMID: 4764560 Spanish. No abstract available.
-
[Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].Fortschr Neurol Psychiatr Grenzgeb. 1972 Oct;40(10):564-8. Fortschr Neurol Psychiatr Grenzgeb. 1972. PMID: 4565521 Clinical Trial. German. No abstract available.
-
[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].Wien Med Wochenschr. 1974 Jun 1;124(22):340-4. Wien Med Wochenschr. 1974. PMID: 4275492 Clinical Trial. German. No abstract available.
-
[Decarboxylase inhibitor given in combination with l-dopa. A new therapeutic principal in parkinsonism].Tidsskr Nor Laegeforen. 1973 Oct 10;93(28):2113-5. Tidsskr Nor Laegeforen. 1973. PMID: 4590070 Review. Norwegian. No abstract available.
-
[Current treatment of Parkinson syndrome with L-dopa].Pol Tyg Lek. 1972 May 22;27(21):798-800. Pol Tyg Lek. 1972. PMID: 4555002 Review. Polish. No abstract available.
Cited by
-
Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.Drugs. 1976;11(5):329-77. doi: 10.2165/00003495-197611050-00001. Drugs. 1976. PMID: 782834 Review. No abstract available.
-
[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].Arch Psychiatr Nervenkr (1970). 1973 Mar 19;217(1):95-112. doi: 10.1007/BF02552835. Arch Psychiatr Nervenkr (1970). 1973. PMID: 4695662 German. No abstract available.